Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions
Guillermo Ortí(Hospital Universitari i Politècnic La Fe), David Valcárcel(Vall d'Hebron Hospital Universitari), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Jorge Sierra(Universitat Autònoma de Barcelona), Isabel Sánchez‐Ortega(European Society for Blood and Marrow Transplantation), Irene García‐Cadenas(Hospital de Sant Pau), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Isabel Badell(Hospital de Sant Pau), José Luís Piñana(Hospital Universitari i Politècnic La Fe), Rocío Parody(Institut Català d'Oncologia), María José Jimenez(Institut Català d'Oncologia), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Carmen Azqueta(Banc de Sang i Teixits), Luisa Sisinni(Hospital de Sant Pau), Laura Alonso(Vall d'Hebron Hospital Universitari), Olga Salamero(Vall d'Hebron Institut de Recerca), Christelle Ferrá(Hospital Universitari Germans Trias i Pujol), Sergi Querol(Banc de Sang i Teixits)
Cited by 21
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k